From: Risk factors of embolism for the cardiac myxoma patients: a systematic review and metanalysis
study | country | type of study | sample size | age(Mean ± SD or median(IQR)) | incidence of embolism | risk factors | the JBI Appraisal Checklist | ||
---|---|---|---|---|---|---|---|---|---|
embolisim group | non-embolism group | embolisim group | non-embolism group | ||||||
Cao 2017 [5] | China | Retrospective case series | 24 | 87 | 36.0 ± 8.1 | 36.4 ± 6.5 | 21.62% | tumor size | yes(6)no(3)unclear(1) not applicable(0) |
Deng 2015 [6] | China | Retrospective case series | 33 | 129 | 48(38–61) | 54(46–63) | 20.37% | tumor location, tumor surface, MPV, PLT | yes(8)no(1)unclear(1) not applicable(0) |
Lee 2012 [7] | Korea | Retrospective case series | 13 | 46 | 59.2 ± 12.6 | 58.3 ± 12.6 | 22.03% | tumor surface | yes(7)no(2)unclear(1) not applicable(0) |
Wang 2016 [8] | China | Retrospective case series | 32 | 175 | 39.7 ± 16.6 | 45.0 ± 15.5 | 15.46% | tumor size, tumor surface | yes(7)no(2)unclear(1) not applicable(0) |
Yin 2016 [9] | China | Retrospective case series | 143 | 322 | 59.4 ± 10.9 | 52.3 ± 12.4 | 44.41% | age, BMI, tumor size, tumor surface, tumor location, LAD CHA2DS2–VASc score | yes(8)no(1)unclear(1) not applicable(0) |
Li 2018 [10] | China | Retrospective case series | 27 | 158 | 48.19 ± 13.11 | 49.39 ± 14.97 | 14.59% | tumor location,tumor base size, FIB | yes(7)no(2)unclear(1) not applicable(0) |
Xu 2016 [11] | China | Retrospective case series | 26 | 156 | 58.54 ± 12.65 | 57.29 ± 11.11 | 14.29% | tumor surface, tumor base size, FIB | yes(8)no(1)unclear(1) not applicable(0) |
Boyacıoğlu 2017 [12] | Turkey | Retrospective case series | 25 | 74 | 49 ± 16.89 | 50.12 ± 15.71 | 25.26% | AF, tumor surface, tumor size | yes(7)no(2)unclear(1) not applicable(0) |
Kalçık 2019 [13] | Turkey | Retrospective case series | 13 | 80 | 50(36–62) | 56(45–65) | 13.98% | LAD, AF, tumor size, tumor surface | yes(7)no(2)unclear(1) not applicable(0) |
Ping 2019 [14] | China | Retrospective case series | 32 | 75 | 54.66 ± 13.21 | 51.72 ± 13.76 | 29.91% | tumor surface, tumor location | yes(7)no(2)unclear(1) not applicable(0) |
Canga 2017 [15] | Turkey | Retrospective case series | 13 | 53 | 51.1 ± 11.4 | 55.9 ± 12.4 | 19.70% | sex,tumor location,tumor surface | yes(7)no(2)unclear(1) not applicable(0) |
Zheng 2014 [16] | China | Retrospective case series | 15 | 63 | 49 ± 9 | 52 ± 6 | 19.23% | tumor surface | yes(7)no(2)unclear(1) not applicable(0) |